These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29985448)

  • 1. Simultaneous GLP-1 receptor activation and angiotensin receptor blockade increase natriuresis independent of altered arterial pressure in obese OLETF rats.
    Rodriguez R; Moreno M; Lee AY; Godoy-Lugo JA; Nakano D; Nishiyama A; Parkes D; Awayda MS; Ortiz RM
    Hypertens Res; 2018 Oct; 41(10):798-808. PubMed ID: 29985448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous angiotensin receptor blockade and glucagon-like peptide-1 receptor activation ameliorate albuminuria in obese insulin-resistant rats.
    Rodriguez R; Escobedo B; Lee AY; Thorwald M; Godoy-Lugo JA; Nakano D; Nishiyama A; Parkes DG; Ortiz RM
    Clin Exp Pharmacol Physiol; 2020 Mar; 47(3):422-431. PubMed ID: 31675433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic AT
    Rodriguez R; Lee AY; Godoy-Lugo JA; Martinez B; Ohsaki H; Nakano D; Parkes DG; Nishiyama A; Vázquez-Medina JP; Ortiz RM
    Am J Physiol Endocrinol Metab; 2021 Nov; 321(5):E714-E727. PubMed ID: 34658252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin receptor blockade increases pancreatic insulin secretion and decreases glucose intolerance during glucose supplementation in a model of metabolic syndrome.
    Rodriguez R; Viscarra JA; Minas JN; Nakano D; Nishiyama A; Ortiz RM
    Endocrinology; 2012 Apr; 153(4):1684-95. PubMed ID: 22355070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic AT1 blockade improves glucose homeostasis in obese OLETF rats.
    Rodriguez R; Minas JN; Vazquez-Medina JP; Nakano D; Parkes DG; Nishiyama A; Ortiz RM
    J Endocrinol; 2018 Jun; 237(3):271-284. PubMed ID: 29643115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin receptor and tumor necrosis factor-α activation contributes to glucose intolerance independent of systolic blood pressure in obese rats.
    Rodriguez R; Lee A; Mathis KW; Broome HJ; Thorwald M; Martinez B; Nakano D; Nishiyama A; Ryan MJ; Ortiz RM
    Am J Physiol Renal Physiol; 2018 Oct; 315(4):F1081-F1090. PubMed ID: 29993275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic angiotensin receptor activation promotes hepatic triacylglycerol accumulation during an acute glucose challenge in obese-insulin-resistant OLETF rats.
    Godoy-Lugo JA; Thorwald MA; Hui DY; Nishiyama A; Nakano D; Soñanez-Organis JG; Ortiz RM
    Endocrine; 2022 Jan; 75(1):92-107. PubMed ID: 34327606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin receptor-mediated oxidative stress is associated with impaired cardiac redox signaling and mitochondrial function in insulin-resistant rats.
    Vázquez-Medina JP; Popovich I; Thorwald MA; Viscarra JA; Rodriguez R; Sonanez-Organis JG; Lam L; Peti-Peterdi J; Nakano D; Nishiyama A; Ortiz RM
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H599-607. PubMed ID: 23771688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved lipogenesis gene expression in liver is associated with elevated plasma angiotensin 1-7 after AT1 receptor blockade in insulin-resistant OLETF rats.
    Godoy-Lugo JA; Mendez DA; Rodriguez R; Nishiyama A; Nakano D; Soñanez-Organis JG; Ortiz RM
    Mol Cell Endocrinol; 2022 Sep; 555():111729. PubMed ID: 35921918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin receptor blockade improves cardiac mitochondrial activity in response to an acute glucose load in obese insulin resistant rats.
    Thorwald M; Rodriguez R; Lee A; Martinez B; Peti-Peterdi J; Nakano D; Nishiyama A; Ortiz RM
    Redox Biol; 2018 Apr; 14():371-378. PubMed ID: 29049981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olmesartan ameliorates a dietary rat model of non-alcoholic steatohepatitis through its pleiotropic effects.
    Kurita S; Takamura T; Ota T; Matsuzawa-Nagata N; Kita Y; Uno M; Nabemoto S; Ishikura K; Misu H; Ando H; Zen Y; Nakanuma Y; Kaneko S
    Eur J Pharmacol; 2008 Jul; 588(2-3):316-24. PubMed ID: 18501344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the AT(1) receptor blocker losartan and the calcium channel blocker benidipine on the accumulation of lipids in the kidney of a rat model of metabolic syndrome.
    Ishizaka N; Hongo M; Matsuzaki G; Furuta K; Saito K; Sakurai R; Sakamoto A; Koike K; Nagai R
    Hypertens Res; 2010 Mar; 33(3):263-8. PubMed ID: 20057486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candesartan restored cardiac Hsp72 expression and tolerance against reperfusion injury in hereditary insulin-resistant rats.
    Taniguchi Y; Takahashi N; Fukui A; Nagano-Torigoe Y; Thuc LC; Teshima Y; Shinohara T; Wakisaka O; Ooie T; Murozono Y; Yufu K; Nakagawa M; Hara M; Yoshimatsu H; Saikawa T
    Cardiovasc Res; 2011 Dec; 92(3):439-48. PubMed ID: 21952935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II type 1 receptor-mediated upregulation of calcineurin activity underlies impairment of cardioprotective signaling in diabetic hearts.
    Hotta H; Miura T; Miki T; Togashi N; Maeda T; Kim SJ; Tanno M; Yano T; Kuno A; Itoh T; Satoh T; Terashima Y; Ishikawa S; Shimamoto K
    Circ Res; 2010 Jan; 106(1):129-32. PubMed ID: 19910577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin receptor blockade recovers hepatic UCP2 expression and aconitase and SDH activities and ameliorates hepatic oxidative damage in insulin resistant rats.
    Montez P; Vázquez-Medina JP; Rodríguez R; Thorwald MA; Viscarra JA; Lam L; Peti-Peterdi J; Nakano D; Nishiyama A; Ortiz RM
    Endocrinology; 2012 Dec; 153(12):5746-59. PubMed ID: 23087176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal angiotensin type 2 receptors mediate natriuresis via angiotensin III in the angiotensin II type 1 receptor-blocked rat.
    Padia SH; Howell NL; Siragy HM; Carey RM
    Hypertension; 2006 Mar; 47(3):537-44. PubMed ID: 16380540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats.
    Nagai Y; Yao L; Kobori H; Miyata K; Ozawa Y; Miyatake A; Yukimura T; Shokoji T; Kimura S; Kiyomoto H; Kohno M; Abe Y; Nishiyama A
    J Am Soc Nephrol; 2005 Mar; 16(3):703-11. PubMed ID: 15647337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous Activation of Glucagon-Like Peptide-1 Receptor Contributes to Blood Pressure Control: Role of Proximal Tubule Na
    Martins FL; Bailey MA; Girardi ACC
    Hypertension; 2020 Sep; 76(3):839-848. PubMed ID: 32755467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin receptor blockade with olmesartan alleviates brain pathology in obese OLETF rats.
    Rodriguez-Ortiz CJ; Thorwald MA; Rodriguez R; Mejias-Ortega M; Kieu Z; Maitra N; Hawkins C; Valenzuela J; Peng M; Nishiyama A; Ortiz RM; Kitazawa M
    Clin Exp Pharmacol Physiol; 2023 Mar; 50(3):228-237. PubMed ID: 36398458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular proliferation and transforming growth factor-beta expression in pre- and early stage of diabetes mellitus in Otsuka Long-Evans Tokushima fatty rats.
    Hosomi N; Noma T; Ohyama H; Takahashi T; Kohno M
    Atherosclerosis; 2002 May; 162(1):69-76. PubMed ID: 11947899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.